Outcome Following Use of Different Concentrations of NaOCl as Wound Lavage and Hemostatic Agent in Partial Pulpotomy
1 other identifier
interventional
128
1 country
1
Brief Summary
The aim of this randomised control trial is to compare the effect of different concentrations of NaOCl on outcome of partial pulpotomy in teeth with clinical signs indicative of irreversible pulpitis. The main question it aims to answer are:
- 1.clinical and radiographic outcome of partial pulpotomy following use of 5% and 3% NaOCl in mature permanent teeth with clinical signs indicative of irreversible pulpitis.
- 2.OHRQoL and pain experience after use of 5% and 3% NaOCl during partial pulpotomy in teeth with clinical signs indicative of irreversible pulpitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 22, 2024
CompletedStudy Start
First participant enrolled
May 23, 2024
CompletedFirst Posted
Study publicly available on registry
May 29, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 23, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 23, 2025
CompletedFebruary 24, 2026
February 1, 2026
1.6 years
May 22, 2024
February 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Clinical success rate
Clinical criteria of success:- 1. No pain or discomfort except for the first few days after treatment. 2. No tenderness to palpation or percussion and the tooth is functional. 3. Normal mobility and probing pocket depth. 4. Healthy soft tissues around teeth with no swelling, sinus tract.
baseline to 12 months
Radiographic success rate
Radiographic success criteria:- 1. No pathosis such as root resorption, furcal pathosis or new periapical pathosis evident on the radiograph. 2. Complete radiographic healing
Baseline to 12 months
Secondary Outcomes (2)
Post Operative Pain
Baseline to 7 days
OHRQoL assessment
baseline and at 24 h, 2, 3, 4, 5, 6 and 7 days after the treatment, and then at 6 and 12 months.
Study Arms (2)
Control: 3% sodium hypochlorite
ACTIVE COMPARATORAfter partial pulpotomy procedure, pulp wound will be irrigated with 3% sodium hypochlorite and haemostasis will be achieved by placing the cotton pellet soaked with 3% sodium hypochlorite on the amputated pulp.
Test: 5% sodium hypochlorite
EXPERIMENTALAfter partial pulpotomy procedure, pulp wound will be irrigated with 5% sodium hypochlorite and haemostasis will be achieved by placing the cotton pellet soaked with 5% sodium hypochlorite on the amputated pulp.
Interventions
After caries removal and pulp exposure pulp tissue is amputated and hemostasis is achieved with 3% sodium hypochlorite in control group and 5% sodium hypochlorite in experimental group followed by capping with 2-3mm layer of MTA. A layer of RMGIC will be placed over the MTA. Then the tooth will be permanently restored with composite resin.
Eligibility Criteria
You may qualify if:
- Mature permanent mandibular molars.
- Teeth with clinical diagnosis of symptomatic irreversible pulpitis
- Patients having normal periapical status with periapical index (PAI) score ≤ 2
- Periodontally healthy teeth
- Patients having physical status of class 1 or 2 according to ASA classification
- Pulpal bleeding can be controlled within 6 minutes.
- Presence of extremely deep carious lesion on radiograph -
You may not qualify if:
- \) Non restorable teeth 2) Necrotic pulp evident upon exposure 3) Negative response to vitality test 4) Presence of sinus tract 5) Presence of soft tissue swelling 6) Radiographic signs of internal or external root resorption 7) Pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
PIGDS
Rohtak, Haryana, 124001, India
Study Officials
- STUDY DIRECTOR
Dr. Pankaj Sangwan, MDS
PGIDS, Rohtak, Haryana 124001
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The operator, patient and the outcome assessor will be masked to the group allocation
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 22, 2024
First Posted
May 29, 2024
Study Start
May 23, 2024
Primary Completion
December 23, 2025
Study Completion
December 23, 2025
Last Updated
February 24, 2026
Record last verified: 2026-02